# Newmark Group, Inc.: financial statements, quarterly

NMRK · Nasdaq · CIK 1690680 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nmrk.md) · [Financials](/companies/nmrk/financials.md) · [Filings](/companies/nmrk/filings.md) · [Insiders](/companies/nmrk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nmrk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [513](/filings/0001690680-24-000031.md) | [641 d](/filings/0001628280-26-013160.md) | [450](/filings/0001628280-25-024261.md) | [527](/filings/0001628280-25-039056.md) | [568](/filings/0001628280-25-051073.md) | [728 d](/filings/0001628280-26-013160.md) | [556](/filings/0001628280-26-032821.md) | [640](/filings/0001628280-26-054877.md) | [715](/filings/0001628280-25-051073.md) | [859 d](/filings/0001628280-26-013160.md) | [718](/filings/0001628280-26-032821.md) | [764](/filings/0001628280-26-054877.md) |
| Operating income | $m | [30.1](/filings/0001690680-24-000031.md) | [79.4 d](/filings/0001628280-26-013160.md) | [(22.6)](/filings/0001628280-25-024261.md) | [40.7](/filings/0001628280-25-039056.md) | [41.1](/filings/0001628280-25-051073.md) | [104 d](/filings/0001628280-26-013160.md) | [(17.5)](/filings/0001628280-26-032821.md) | [42.7](/filings/0001628280-26-054877.md) | [85.2](/filings/0001628280-25-051073.md) | [124 d](/filings/0001628280-26-013160.md) | [27.0](/filings/0001628280-26-032821.md) | [40.4](/filings/0001628280-26-054877.md) |
| Income tax | $m | [8.4](/filings/0001690680-24-000031.md) | [29.1 d](/filings/0001628280-26-013160.md) | [(3.5)](/filings/0001628280-25-024261.md) | [9.0](/filings/0001628280-25-039056.md) | [8.8](/filings/0001628280-25-051073.md) | [31.4 d](/filings/0001628280-26-013160.md) | [(10.1)](/filings/0001628280-26-032821.md) | [4.2](/filings/0001628280-26-054877.md) | [18.7](/filings/0001628280-25-051073.md) | [33.2 d](/filings/0001628280-26-013160.md) | [3.4](/filings/0001628280-26-032821.md) | [9.6](/filings/0001628280-26-054877.md) |
| Net income | $m | [9.9](/filings/0001690680-24-000031.md) | [56.3 d](/filings/0001213900-26-050004.md) | [(16.3)](/filings/0001628280-25-024261.md) | [14.3](/filings/0001628280-25-039056.md) | [17.8](/filings/0001628280-25-051073.md) | [69.7 d](/filings/0001213900-26-050004.md) | [(8.8)](/filings/0001628280-26-032821.md) | [20.8](/filings/0001628280-26-054877.md) | [46.2](/filings/0001628280-25-051073.md) | [68.0 d](/filings/0001628280-26-013160.md) | [14.4](/filings/0001628280-26-032821.md) | [19.7](/filings/0001628280-26-054877.md) |
| Diluted EPS | $ per share | [0.06](/filings/0001690680-24-000031.md) | not reported | [(0.09)](/filings/0001628280-25-024261.md) | [0.08](/filings/0001628280-25-039056.md) | [0.10](/filings/0001628280-25-051073.md) | not reported | [(0.05)](/filings/0001628280-26-032821.md) | [0.11](/filings/0001628280-26-054877.md) | [0.25](/filings/0001628280-25-051073.md) | not reported | [0.08](/filings/0001628280-26-032821.md) | [0.11](/filings/0001628280-26-054877.md) |
| Basic EPS | $ per share | [0.06](/filings/0001690680-24-000031.md) | not reported | [(0.09)](/filings/0001628280-25-024261.md) | [0.08](/filings/0001628280-25-039056.md) | [0.10](/filings/0001628280-25-051073.md) | not reported | [(0.05)](/filings/0001628280-26-032821.md) | [0.12](/filings/0001628280-26-054877.md) | [0.26](/filings/0001628280-25-051073.md) | not reported | [0.08](/filings/0001628280-26-032821.md) | [0.11](/filings/0001628280-26-054877.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [143](/filings/0001690680-23-000039.md) | [165](/filings/0001628280-25-009332.md) | [141](/filings/0001690680-24-000015.md) | [176](/filings/0001690680-24-000025.md) | [179](/filings/0001628280-25-051073.md) | [198](/filings/0001628280-26-013160.md) | [157](/filings/0001628280-26-032821.md) | [196](/filings/0001628280-26-054877.md) | [224](/filings/0001628280-25-051073.md) | [229](/filings/0001628280-26-054877.md) | [212](/filings/0001628280-26-032821.md) | [260](/filings/0001628280-26-054877.md) |
| Current assets | $m | [1,485](/filings/0001690680-23-000039.md) | [1,506](/filings/0001628280-25-009332.md) | [1,377](/filings/0001690680-24-000015.md) | [1,760](/filings/0001690680-24-000025.md) | [1,993](/filings/0001690680-24-000031.md) | [1,773](/filings/0001628280-26-013160.md) | [1,787](/filings/0001628280-25-024261.md) | [2,344](/filings/0001628280-25-039056.md) | [2,443](/filings/0001628280-25-051073.md) | [2,005](/filings/0001628280-26-054877.md) | [2,273](/filings/0001628280-26-032821.md) | [2,100](/filings/0001628280-26-054877.md) |
| Total assets | $m | [4,435](/filings/0001690680-23-000039.md) | [4,472](/filings/0001628280-25-009332.md) | [4,422](/filings/0001690680-24-000015.md) | [4,759](/filings/0001690680-24-000025.md) | [5,004](/filings/0001690680-24-000031.md) | [4,710](/filings/0001628280-26-013160.md) | [4,848](/filings/0001628280-25-024261.md) | [5,390](/filings/0001628280-25-039056.md) | [5,460](/filings/0001628280-25-051073.md) | [5,019](/filings/0001628280-26-054877.md) | [5,279](/filings/0001628280-26-032821.md) | [5,188](/filings/0001628280-26-054877.md) |
| Current liabilities | $m | [1,598](/filings/0001690680-23-000039.md) | [1,490](/filings/0001628280-25-009332.md) | [1,370](/filings/0001690680-24-000015.md) | [1,696](/filings/0001690680-24-000025.md) | [1,962](/filings/0001690680-24-000031.md) | [1,780](/filings/0001628280-26-013160.md) | [1,764](/filings/0001628280-25-024261.md) | [2,259](/filings/0001628280-25-039056.md) | [2,372](/filings/0001628280-25-051073.md) | [1,907](/filings/0001628280-26-054877.md) | [2,100](/filings/0001628280-26-032821.md) | [1,920](/filings/0001628280-26-054877.md) |
| Total liabilities | $m | [2,921](/filings/0001690680-23-000039.md) | [2,877](/filings/0001628280-25-009332.md) | [2,855](/filings/0001690680-24-000015.md) | [3,222](/filings/0001690680-24-000025.md) | [3,512](/filings/0001690680-24-000031.md) | [3,172](/filings/0001628280-26-013160.md) | [3,288](/filings/0001628280-25-024261.md) | [3,865](/filings/0001628280-25-039056.md) | [3,829](/filings/0001628280-25-051073.md) | [3,267](/filings/0001628280-26-054877.md) | [3,587](/filings/0001628280-26-032821.md) | [3,439](/filings/0001628280-26-054877.md) |
| Long-term debt | $m | [475](/filings/0001690680-23-000039.md) | [547](/filings/0001628280-25-009332.md) | [670](/filings/0001690680-24-000015.md) | [745](/filings/0001690680-24-000025.md) | [770](/filings/0001690680-24-000031.md) | [671](/filings/0001628280-26-013160.md) | [771](/filings/0001628280-25-024261.md) | [871](/filings/0001628280-25-039056.md) | [746](/filings/0001628280-25-051073.md) | [672](/filings/0001628280-26-054877.md) | [832](/filings/0001628280-26-032821.md) | [867](/filings/0001628280-26-054877.md) |
| Current portion of debt | $m | [130](/filings/0001690680-23-000039.md) | [0.0](/filings/0001690680-24-000006.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,190](/filings/0001690680-23-000039.md) | [1,253](/filings/0001628280-25-009332.md) | [1,232](/filings/0001690680-24-000015.md) | [1,203](/filings/0001690680-24-000025.md) | [1,171](/filings/0001690680-24-000031.md) | [1,206](/filings/0001628280-26-013160.md) | [1,321](/filings/0001628280-25-024261.md) | [1,280](/filings/0001628280-25-039056.md) | [1,368](/filings/0001628280-25-051073.md) | [1,462](/filings/0001628280-26-054877.md) | [1,399](/filings/0001628280-26-032821.md) | [1,437](/filings/0001628280-26-054877.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [414 d](/filings/0001690680-24-000031.md) | [220 d](/filings/0001628280-26-013160.md) | [(68.8)](/filings/0001628280-25-024261.md) | [(258) d](/filings/0001628280-25-039056.md) | [(85.2) d](/filings/0001628280-25-051073.md) | [403 d](/filings/0001628280-26-013160.md) | [(179)](/filings/0001628280-26-032821.md) | [(380) d](/filings/0001628280-26-054877.md) | [113 d](/filings/0001628280-25-051073.md) | [619 d](/filings/0001628280-26-013160.md) | [(248)](/filings/0001628280-26-032821.md) | [362 d](/filings/0001628280-26-054877.md) |
| Capital expenditure | $m | [10.2 d](/filings/0001690680-24-000031.md) | [11.5 d](/filings/0001628280-26-013160.md) | [7.0](/filings/0001628280-25-024261.md) | [9.3 d](/filings/0001628280-25-039056.md) | [9.2 d](/filings/0001628280-25-051073.md) | [6.0 d](/filings/0001628280-26-013160.md) | [5.4](/filings/0001628280-26-032821.md) | [6.5 d](/filings/0001628280-26-054877.md) | [7.7 d](/filings/0001628280-25-051073.md) | [9.7 d](/filings/0001628280-26-013160.md) | [10.2](/filings/0001628280-26-032821.md) | [20.8 d](/filings/0001628280-26-054877.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [18.9 d](/filings/0001690680-24-000031.md) | [5.2 d](/filings/0001628280-26-013160.md) | [37.2](/filings/0001628280-25-024261.md) | [55.5 d](/filings/0001628280-25-039056.md) | [89.6 d](/filings/0001628280-25-051073.md) | [30.4 d](/filings/0001628280-26-013160.md) | [0.0](/filings/0001628280-26-032821.md) | [126 d](/filings/0001628280-26-054877.md) | [0.0 d](/filings/0001628280-25-051073.md) | [1.5 d](/filings/0001628280-26-013160.md) | [136](/filings/0001628280-26-032821.md) | [14.8 d](/filings/0001628280-26-054877.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [243](/filings/0001690680-23-000039.md) | [173](/filings/0001690680-24-000015.md) | [245](/filings/0001690680-24-000025.md) | [247](/filings/0001690680-24-000031.md) | [175](/filings/0001628280-25-024261.md) | [256](/filings/0001628280-25-039056.md) | [255](/filings/0001628280-25-051073.md) | [176](/filings/0001628280-26-032821.md) | [253](/filings/0001628280-26-054877.md) | [252](/filings/0001628280-25-051073.md) | [256](/filings/0001628280-26-032821.md) | [252](/filings/0001628280-26-054877.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.